Microvascular decompression provides an appropriate therapeutic choice if vascular compression of the trigeminal nerve is identified. From our 2 cases, we propose that, in some cases of SUNCT diagnosed previously, characteristic symptoms were induced by compression of the side surface of the first branch of the trigeminal nerve at the root exit zone by the intracranial artery.
. C a r o t i d 3 D r o t a t i o n a l a n g i o g r a p h i e s a n t e r o p o s t e r i o r ( C ) a n d l a t e r a l ( D) v i e ws o n e x t e n s i v e s t e n o s i
s wi t h a d o u b l e l u me n f r o m M1 ( a r r o ws ) t o M2 p r o x i ma l s e g me n t ( a r r o w h e a d s ) . Hi g h e r ma g n i f i c a t i o n i ma g e o f d i s s e c t i o n i n MC A i s s h o wn i n t h e i n s e t . R i g h t c a r o t i d a n g i o g r a m o b t a i n e d 1 mo n t h a f t e r r i g h t S TA-MC A a n a s t o mo s i s s h o wi n g i mp r o v e me n t o f t h e s t e n o s i s i n MC A M1 a n d M1 -M2 b i f u r c a t i o n . P a r t s o f s t e n o s i s a n d d i s s e c t i o n a r e p o i n t e d o u t b y a r r o ws ( E ) .
The objective of this retrospective study was to report initial results of CyberKnife stereotactic radiotherapy (SRT) boost for tumors in the head and neck area. Between March 2008 and August 2009, 10 patients were treated with SRT boost using CyberKnife system due mainly to unfavorable condition such as tumors in close proximity to serial organs or former radiotherapy fields. Treatment sites were the external auditory canal in two, the nasopharynx in one, the oropharynx in three, the nasal cavity in one, the maxillary sinus in two, and the oligometastatic cervical lymph node in one. All patients underwent preceding conventional radiotherapy of 40 to 60 Gy. Dose and fractionation scheme of the Cyberknife SRT boost was individualized, and prescribed dose ranged from 9 Gy to 16 Gy in 3 to 4 fractions. Among four patients for whom dose to the optic pathway was concerned, the maximum dose was only about 3 Gy for three patients whereas 9.6 Gy in the remaining one patient. The maximum dose for the mandible in one of three patients with oropharyngeal cancer was 19.7 Gy, whereas majority of the bone can be spared by using non-isocentric conformal beams. For a patient with nasopharyngeal cancer, the highest dose in the brain stem was 15 Gy. However, majority of the brain stem received less than 40% of the maximum dose. Although a small volume high dose area within the normal structure could be observed in several patients, results of the present study showed potential benefits of the CyberKnife SRT boost.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.